Evening primrose oil is one of the older botanical oils in the skin-health category, valued for its gamma-linolenic acid (GLA) content, and brands abroad ask for a Japan-made version alongside other beauty-oil ingredients.
This guide is for brand owners planning an evening primrose oil product made in Japan. It sets out what the clinical trial evidence shows, including a Cochrane review that reached a different conclusion from some individual trials, Japan’s food status for the ingredient, and the formulation questions that matter for an oxidation-sensitive oil.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning an evening primrose oil product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
A 2013 Cochrane review of 27 trials found that oral evening primrose oil did not significantly improve skin symptoms over placebo, while at least one smaller, later trial reported a benefit — the overall picture across studies is mixed.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Cochrane systematic review, Cochrane Database of Systematic Reviews 2013 (PMID 23633319) | 27 randomised controlled trials, 1,596 participants; 19 trials of evening primrose oil and 8 of borage oil, in people with eczema | Evening primrose oil did not significantly improve global skin symptoms over placebo on either participant- or doctor-rated scales; the authors concluded oral evening primrose oil is not an effective treatment for eczema |
| Randomised, double-blind, placebo-controlled trial, Annals of Dermatology 2018 (PMID 30065580) | 50 patients with mild atopic dermatitis; 450 mg evening primrose oil (40 mg GLA) per capsule or soybean oil placebo, 4 months | Significant improvement in the EASI skin-severity score in the evening primrose oil group versus no significant change in placebo; transepidermal water loss and skin hydration improved slightly but not significantly |
Two points worth keeping in view:
- The larger, pooled evidence points one way; a smaller, later trial points the other. The Cochrane review’s conclusion is based on many more trials and participants than the 2018 study, and is the more reliable overall summary of the evidence to date.
- Research populations had a skin condition. Both studies enrolled people with diagnosed eczema or atopic dermatitis. That is a fact about the research, not a basis for a condition-linked claim about a supplement sold to the general public.
- Funding. The Cochrane review discloses that one of the included trials was funded by a grant later repaid by an evening primrose oil manufacturer, which supplied the study medication, placebo and blood testing — a detail the review reports for transparency about one of its 27 included trials, not the review itself.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Evening primrose seed oil sits on the Japanese list of ingredients not judged to be medicines unless a medicinal claim is made, which is why it is sold in Japan as a general food ingredient.
Japan’s food-drug classification system (食薬区分) maintains a list of substances treated exclusively as medicines and a separate list of substances not judged to be medicines provided the product does not claim a medicinal effect. Evening primrose oil (ツキミソウ油), seed oil, sits on the non-medicinal list. That status is why it is sold across Japan as a general food ingredient in soft capsules, through ordinary retail channels.
Being food-usable is a separate question from carrying a notified function. A Japanese company wishing to state a specific function for an evening primrose oil product under the Foods with Function Claims system would need its own notification and its own supporting evidence for that exact product.
💬 Need an evidence summary for your regulatory adviser that reflects both the Cochrane finding and the smaller positive trial honestly? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe evening primrose oil by its GLA content and what has been studied, and be explicit that the larger body of evidence found no benefit over placebo.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains evening primrose oil with a stated GLA content” | Any skin-condition name, or “treats” or “cures” eczema or dermatitis |
| ”Studied for skin comfort measures; overall trial evidence is mixed" | "Clinically proven” without naming the study and its result |
| Naming the amount of oil and GLA per serving | Implying a guaranteed effect on skin symptoms |
How evening primrose oil is formulated
Evening primrose oil is a liquid oil rich in polyunsaturated fatty acids, so it is formulated almost exclusively as a soft capsule to control oxidation.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Soft capsule | The standard format for a liquid oil; protects the oil from air and light until use | Shell material, and oxidation protection during and after manufacture |
| Blend with other oils | Combines with borage oil, fish oil or other beauty oils | Each companion oil needs its own oxidation and stability plan |
Decisions that shape the specification:
- GLA content. Evening primrose oil is typically standardised to a guaranteed GLA percentage. Ask the supplier for the specification and the extraction method (commonly cold-pressed or solvent-extracted seed oil).
- Amount per serving. Match the amount to a specific study if you plan to cite one — the 2018 trial above used 450 mg of oil (40 mg GLA) per capsule.
- Oxidation and stability. Polyunsaturated oils are prone to oxidation. Antioxidant addition (such as vitamin E), nitrogen-flushed filling, and opaque or barrier packaging are common ways manufacturers manage shelf-life.
- Companion ingredients. Evening primrose oil is sometimes combined with other beauty-oriented ingredients. Each companion needs its own check against Japanese food law.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Evening primrose seed oil itself is established in Japanese foods. Companion botanicals in combined beauty formulas are where a check most often turns up a problem. See the Japan-made supplement OEM page, and compare with our hyaluronic acid and astaxanthin guides.
Before you ask for a quotation
A factory can quote accurately once the GLA standardisation, the amount, the oxidation plan and the packaging are fixed.
- Evening primrose oil source and GLA standardisation percentage
- Amount per serving and servings per pack
- Antioxidant and packaging plan for oxidation control
- Companion ingredients and their amounts
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made evening primrose oil product? Send us the concept — GLA standardisation, amount, oxidation plan and the countries you will sell in.
Frequently asked questions
1. Does evening primrose oil help with skin symptoms?
The largest body of evidence, a 2013 Cochrane review of 27 trials, found no significant benefit over placebo for skin symptoms. A smaller 2018 trial reported improvement in one skin-severity score. Describe the ingredient as studied, with the overall picture honestly reported as mixed.
2. Why does the Cochrane review disagree with some individual trials?
The Cochrane review pooled results from many more trials and participants than any single study, which is generally considered more reliable than one smaller trial. Individual trials can show a positive result by chance or due to differences in population and dose.
3. Is evening primrose oil legal to sell as a food in Japan?
Yes. Evening primrose seed oil sits on Japan’s list of ingredients not judged to be medicines unless a medicinal claim is made, which is why it is sold there as a general food ingredient.
4. Why is evening primrose oil almost always a soft capsule?
It is a liquid oil rich in polyunsaturated fatty acids, which oxidise readily when exposed to air and light. A soft capsule, ideally with an antioxidant and appropriate packaging, protects the oil until the consumer opens the pack.
5. What dose was used in the positive trial?
The 2018 Korean trial used 450 mg of evening primrose oil, providing 40 mg of GLA, per capsule, taken for four months.
Sources: “Oral evening primrose oil and borage oil for eczema”, Cochrane Database of Systematic Reviews 2013 (PMID 23633319); “Effect of Evening Primrose Oil on Korean Patients With Mild Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Study”, Annals of Dermatology 2018 (PMID 30065580); Japan Ministry of Health, Labour and Welfare 食薬区分における成分本質（原材料）の取扱いの例示. Checked on 25 September 2026.